B

Coca-Cola (KO) 2025 — $200B IRS Dispute, 64-Year Dividend Streak

KO·2025·English

Grade: F — Major Red Flags

Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles

Data: SEC EDGAR 10-K (Filed 2026-02-20, FY ended December 31, 2025) + Yahoo Finance

Auditor: Ernst & Young LLP — Unqualified opinion (2 critical audit matters: uncertain tax positions, indefinite-lived trademark valuation)

One-line verdict: Coca-Cola's brand power is undeniable — 2.2 billion servings consumed daily, gross margins expanding to 61.6%, and unit case volume at 33.8 billion cases. But the financials tell a different story than the brand story. Operating cash flow of $7.4B covers only 57% of $13.1B net income — the second consecutive year below 1.0x. Free cash flow of $5.3B is less than half of net income for two consecutive years. Cash of $15.8B covers just 35% of $45.5B in total debt, a critical fail. Goodwill and intangibles of $28.0B represent 87% of equity. And looming over everything: a $6.0B IRS tax deposit already paid for 2007-2009, with an estimated additional $14B in potential liability for 2010-2025 if the company loses its transfer pricing appeal. Three quantitative red flags plus a $20B tax time bomb make this a clear F.

MetricResult
Red Flags**3** (FCF < 50% NI two years, cash covers 35% of debt, goodwill+intangibles 87% of equity)
Watch Items**3** (CFFO/NI 0.57, accruals 5.4%, write-offs up 91%)
Checks Completed**18/18**
Beneish M-Score**-2.35** (clean; threshold is -2.22)
Altman Z-Score**4.72** (safe zone)
AuditorErnst & Young LLP — Unqualified opinion, 2 critical audit matters

The Business: Concentrate Economics and Bottling Complexity

Coca-Cola operates two lines of business: concentrate operations (59% of revenue, 85% of unit case volume) and finished product operations (41% of revenue, 15% of unit case volume). The concentrate model — selling syrups and beverage bases to independent bottlers — is one of the highest-margin business models in consumer goods. Per the filing: "Generally, finished product operations generate higher net operating revenues but lower gross profit margins than concentrate operations."

The company owns or licenses brands in five categories: Trademark Coca-Cola, sparkling flavors, water/sports/coffee/tea, juice/value-added dairy/plant-based beverages, and emerging beverages. The Coca-Cola system sold 33.8 billion unit cases worldwide in FY2025, essentially flat versus 33.7 billion in FY2024.

Revenue by operating segment growth:

SegmentVolume ChangePrice/MixCurrencyAcquisitions/DivestituresRevenue Change
EMEA+4%+2%-1%--+5%
Latin America-1%+11%-12%---2%
North America-1%+5%----+4%
Asia Pacific+1%+4%-3%-1%+1%
Bottling Investments+2%-2%-7%-8%--
**Consolidated****+1%****+4%****-2%****-1%****+2%**

The story is price/mix carrying the entire company. Underlying volume growth is essentially zero. North America volume declined 1% with Trademark Coca-Cola, sparkling flavors, and juice all falling. Latin America was flat on volume but delivered 11% price/mix — a hyperinflationary pricing environment that masked real demand weakness. Mexico volume declined 4%.

Profitability: Headline Numbers

MetricFY2023FY2024FY2025Trend
Net Revenue$45.8B$47.1B$47.9B+4.8% over 3 years
Net Income$10.7B$10.6B$13.1B+22% (but FY2024 had BodyArmor impairment)
Gross Margin59.5%61.1%61.6%Rising 3 consecutive years
Operating Income$11.3B$10.0B$13.8BVolatile — impairments/charges
Diluted EPS$2.47$2.46$3.04+23% YoY
Effective Tax Rate17.4%18.6%17.9%Stable

FY2024 operating income was depressed by $4.2B in "other operating charges" versus $1.3B in FY2025 and $2.0B in FY2023. The 10-K discloses that FY2024 charges included a $760M BodyArmor trademark impairment and FY2025 included an additional $960M BodyArmor trademark impairment. Per the filing: "The decrease in fair value was primarily driven by the revised projections of future operating results, including a slowing of the projected long-term growth rate for the category, an intensifying competitive environment, and more focused innovation and international rollout plans." The remaining BodyArmor trademark carrying value is $2.4B, and the filing warns: "If the near-term operating results of this trademark do not achieve our revised financial projections... it is likely that we would be required to recognize an additional impairment charge."

Equity income from bottling partners was $2.0B, up from $1.8B — reflecting Coca-Cola's significant equity method investments in global bottlers ($20.2B on the balance sheet).

Cash Flow: The Central Problem

The consolidated statements of cash flows tell the most troubling story:

MetricFY2023FY2024FY2025
Operating Cash Flow$11.6B$6.8B$7.4B
Net Income$10.7B$10.6B$13.1B
**CFFO / Net Income****1.08****0.64****0.57**
CapEx$1.9B$2.1B$2.1B
Free Cash Flow$9.7B$4.7B$5.3B
**FCF / Net Income****0.91****0.45****0.40**

CFFO/NI has collapsed from 1.08 in FY2023 to 0.57 in FY2025. Free cash flow covers only 40% of net income. This is the primary reason for the F grade.

What is consuming the cash? The filing explains: "Net cash provided by operating activities for the years ended December 31, 2025 and 2024 was $7,408 million and $6,805 million, respectively, an increase of $603 million, or 9%. This increase was primarily driven by strong cash operating results, lower tax payments, the timing of changes in working capital and lower contributions to The Coca-Cola Foundation compared to the prior year."

The critical items in the cash flow reconciliation:

·Net change in operating assets and liabilities consumed $7.2B (vs. $6.2B in FY2024 and only $846M in FY2023). This massive working capital swing is the primary driver of the CFFO collapse.
·FY2025 included a $6.1B final milestone payment for fairlife — the dairy brand Coca-Cola acquired full ownership of. This $6.1B cash outflow is classified within operating activities and is a major one-time drag.
·FY2024 included the $6.0B IRS Tax Litigation Deposit. While classified in operating activities for cash flow purposes, this was recorded in noncurrent assets on the balance sheet.
·Depreciation and amortization of $1.1B is modest relative to net income — Coca-Cola's asset-light concentrate model has limited D&A to add back.

The fairlife payment ($6.1B) and the IRS deposit ($6.0B) are large one-time items. But even adjusting for these, the underlying CFFO trend is weak because equity income ($2.0B) exceeds dividends received from equity investees by $1.0B — meaning $1.0B of reported income has no cash backing.

Trade receivable factoring is significant. The filing discloses: "The Company sold $14,710 million and $21,873 million of trade accounts receivables under this program during the years ended December 31, 2025 and 2024, respectively." Coca-Cola is actively selling receivables to improve cash flow optics. The cost was $60M in FY2025. The $7.2B drop in factoring volume from FY2024 partially explains the working capital deterioration. Without this factoring program, trade receivables — and the cash flow picture — would look worse.

The 18-Point Screening

Revenue Quality

#CheckResultDetail
A1DSO ChangePASSDSO 23 days, improved -5 days YoY
A2AR vs Revenue GrowthPASSAR declined -14.9% vs revenue growth +1.9%
A3Revenue vs CFFOPASSRevenue +1.9%, CFFO +8.9%

Revenue quality screens clean. The DSO improvement and AR decline are partly attributable to the factoring program selling receivables off the balance sheet, but the directionality is positive.

Expense Quality

#CheckResultDetail
B1Inventory vs COGSPASSInventory -6.4% vs COGS +0.4%. Normal
B2CapEx vs RevenuePASSCapEx growth +2.3% vs revenue +1.9%. Normal
B3SG&A RatioPASSSG&A/Gross Profit = 49.2%. Normal for consumer staples
B4Gross MarginPASS61.6%, +0.6pp. Stable and expanding

Gross margin has expanded from 58.1% to 61.6% over four years — a remarkable run for a mature consumer staples company. This reflects pricing power and favorable mix shift toward concentrate operations. Inventory declined 6.4% (from $4.7B to $4.4B) while COGS was flat, indicating efficient inventory management.

Cash Flow Quality

#CheckResultDetail
C1CFFO vs Net IncomeWATCHCFFO/NI = 0.57. Below 1.0
C2Free Cash FlowFAILFCF < 50% of Net Income for 2 consecutive years
C3Accruals RatioWATCH5.4%. Elevated
C4Cash vs DebtFAILCash $15.8B covers only 35% of debt $45.5B

C2 is the most damning flag. FCF has been below 50% of net income for two consecutive years — a strong signal that reported earnings are not translating into cash. While the fairlife and IRS payments explain the magnitude, the pattern itself triggers the screen.

C4 — Severe debt coverage gap. Total cash, cash equivalents, short-term investments and marketable securities of $15.8B covers only 35% of total debt ($42.1B long-term + $1.8B current maturities + $1.6B loans/notes payable = $45.5B). Per the filing, the company had "$6.2 billion in unused backup lines of credit for general corporate purposes." Even adding backup lines, total available liquidity of $22.0B covers less than half of total debt.

C3 — Accruals ratio of 5.4% is elevated, meaning a meaningful portion of earnings exists as accruals rather than cash. Combined with the CFFO/NI ratio of 0.57, this confirms that income quality is below par.

Balance Sheet

#CheckResultDetail
D1Goodwill + IntangiblesFAILGoodwill+Intangibles $28.0B = 87% of equity
D2LeveragePASSDebt/EBITDA = 2.4x. Acceptable
D3Soft Asset GrowthPASSOther assets 9.6% vs revenue 1.9%. Normal
D4Asset ImpairmentWATCHWrite-offs up 91% YoY

D1 — Goodwill and intangibles dominate the balance sheet. Goodwill of $15.5B (down from $18.1B, reflecting divestitures) and trademarks with indefinite lives of $12.5B (down from $13.3B, reflecting the $960M BodyArmor impairment) total $28.0B — 87% of equity. E&Y identified trademark valuation as a critical audit matter.

The BodyArmor acquisition in November 2021 has been a serial destroyer of value: $760M impairment in FY2024 and $960M in FY2025. The remaining $2.4B carrying value faces further impairment risk per the filing. The original acquisition valued BodyArmor's 85% stake at a total enterprise value that implied a premium to the sports drink market that has not materialized.

D4 — Write-offs up 91% YoY reflects the BodyArmor impairment acceleration plus divestitures (Nigeria operations, India bottling operations refranchising).

D2 — Debt/EBITDA of 2.4x is manageable, and interest coverage at 9.0x provides adequate servicing capacity (interest expense $1.65B on $13.8B operating income). The Z-Score of 4.72 places Coca-Cola firmly in the safe zone for bankruptcy risk.

Acquisition Risk

#CheckResultDetail
E1Serial Acquirer FCFPASSFCF after acquisitions positive
E2Goodwill SurgePASSGoodwill+Intangibles change -11% YoY. Normal

Goodwill actually declined 11% due to divestitures (Nigeria, India refranchising). Coca-Cola is simplifying, not acquiring.

Manipulation Score

#CheckResultDetail
F1Beneish M-ScorePASS-2.35 (threshold: < -2.22)

M-Score of -2.35 is clean but not by a wide margin. Components: DSRI 0.836 (improved), GMI 0.991, AQI 0.958, SGI 1.019, DEPI 0.959, SGAI 0.978, TATA 0.054, LVGI 0.899. The TATA (Total Accruals to Total Assets) at 0.054 is the highest component and consistent with the elevated accruals ratio flagged in C3.

Key Risks from the 10-K

1. The $20 Billion IRS Tax Dispute — Existential if Lost

This is by far Coca-Cola's largest risk. Per the filing:

"On August 2, 2024, the Tax Court entered a decision reflecting additional federal income tax of $2.7 billion for the 2007 through 2009 tax years. With applicable interest, the total liability for the 2007 through 2009 tax years resulting from the Tax Court's decision is $6.0 billion." The company paid this $6.0B deposit on September 10, 2024.

"The Company estimates that the potential aggregate remaining incremental tax and interest liability for the tax years 2010 through 2025 could be approximately $14 billion as of December 31, 2025."

The total potential exposure: $6.0B already deposited + $14B additional = $20B. On a balance sheet with $32.2B in shareholder equity, a $20B hit would be catastrophic.

The core dispute is transfer pricing — specifically, how much income from Coca-Cola's foreign licensees should be allocated to the U.S. parent. On October 1, 2025, the Eighth Circuit reversed the 3M case on similar blocked-income regulation grounds, which is "highly supportive of the Company's position." The company "strongly disagrees with the IRS positions" and is appealing to the Eleventh Circuit.

Per the filing: "While we believe it is more likely than not that we will ultimately prevail in this litigation upon appeal, it is possible that all, or some portion of, the adjustments proposed by the IRS and sustained by the Tax Court could ultimately be upheld."

2. BodyArmor: $1.72B in Cumulative Impairments and Counting

Per the filing, Coca-Cola recorded $960M in BodyArmor trademark impairment in Q4 2025, following $760M in Q1 2024. The filing attributes the decline to "a slowing of the projected long-term growth rate for the category, an intensifying competitive environment, and more focused innovation and international rollout plans." The remaining carrying value of $2.4B faces continued impairment risk if "near-term operating results do not achieve our revised financial projections."

3. Supply Chain Finance and Receivable Factoring

Coca-Cola's 120-day payment terms with suppliers are extended through a supply chain finance (SCF) program where "financial institutions offer a voluntary supply chain finance program which enables our suppliers, at their sole discretion, to sell their receivables from the Company to these financial institutions on a non-recourse basis." Meanwhile, the company itself factors $14.7B of its own trade receivables. These programs are legitimate but create opacity around true working capital dynamics.

4. Foreign Currency Headwinds

Currency movements reduced consolidated revenue by 2% in FY2025. Latin America delivered 11% price/mix growth but -12% from currency — meaning all of the Latin American pricing gains were consumed by devaluation. With operations in 200+ countries, Coca-Cola's dollar-reported results are hostage to FX movements.

5. Volume Stagnation in Developed Markets

North America unit case volume declined 1% with Trademark Coca-Cola, sparkling flavors, and juice all falling. The company is growing revenue through pricing, not demand. As the filing acknowledges: "Consumers may seek to reduce discretionary spending by forgoing purchases of our products or by shifting away from our beverages to lower-priced products offered by other companies, including private-label brands."

Summary

Grade: F. Three quantitative red flags plus a $20B tax contingency make this the most risk-laden blue chip in consumer staples.

Coca-Cola's brand franchise is unmatched: 61.6% gross margins, global distribution through independent bottlers, and dividend aristocrat status. The M-Score of -2.35 and Z-Score of 4.72 both pass. E&Y issued an unqualified opinion.

But the cash flow quality is severely impaired. CFFO/NI of 0.57 and FCF/NI of 0.40 mean that for every dollar of reported profit, only 40-57 cents arrives as cash. The $6.1B fairlife milestone payment and $7.2B working capital drain are real cash out the door. Cash covers only 35% of $45.5B in total debt. Goodwill and intangibles at 87% of equity are dominated by a BodyArmor trademark that has already been impaired by $1.72B.

The IRS transfer pricing dispute dwarfs everything. A $6.0B deposit is already paid; $14B in additional potential liability hangs over the balance sheet. If the Eleventh Circuit rules against Coca-Cola, the financial impact would be material — potentially exceeding total annual net income.

The brand is unbreakable. The balance sheet is not.

**Disclaimer**: This report is based on The Coca-Cola Company's FY2025 10-K filed with SEC EDGAR on February 20, 2026. This is NOT investment advice.

Data: SEC EDGAR 10-K + Yahoo Finance

Auditor: Ernst & Young LLP (Unqualified opinion, 2 critical audit matters — uncertain tax positions, indefinite-lived trademark valuation)

Fiscal year ended: December 31, 2025

This report is based on SEC 10-K filings and public financial data. Not investment advice.

Coca-Cola (KO) 2025 — $200B IRS Dispute, 64-Year Dividend Streak — EarningsGrade